I think that's a bit short sighted lol - but no doubt they would have some idea about the real cost down the track...
The cap raise has covered the cost (hopefully) of completing clinical trials - the cost of actually getting a drug into market is far greater than that though and it's not just about marketing it. Sure it's a very small population but manufacturing product for a drug in market as opposed to a few participating in a clinical trial is a completely different thing and often one of the problems for small companies not in the know often bottlenecks without their own facilities.
Still a long way off before we need to worry about that yet …. but it will come in time if proves successful.
PYC Price at posting:
6.2¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)